← FDA Drug Approvals (Drugs@FDA)
EVEROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2025-01-10
Drug application
- FDA Application #
ANDA218863- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EVEROLIMUS
- Generic name
- EVEROLIMUS
- Active ingredients
- EVEROLIMUS
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AMNEAL
- Manufacturer
- Amneal Pharmaceuticals NY LLC
- First approval
- 2025-01-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown